Huang Z - Search Results

1

HBV integrations reshaping genomic structures promote hepatocellular carcinoma.

Qian Z, Liang J, Huang R, Song W, Ying J, Bi X, Zhao J, Shi Z, Liu W, Liu J, Li Z, Zhou J, Huang Z, Zhang Y, Zhao D, Wu J, Wang L, Chen X, Mao R, Zhou Y, Guo L, Hu H, Ge D, Li X, Luo Z, Yao J, Li T, Chen Q, Wang B, Wei Z, Chen K, Qu C, Cai J, Jiao Y, Bao L, Zhao H. Qian Z, et al. Among authors: huang r, huang z. Gut. 2024 Feb 23:gutjnl-2023-330414. doi: 10.1136/gutjnl-2023-330414. Online ahead of print. Gut. 2024. PMID: 38395437 Free article.

2

Prognostic significance of the preoperative alkaline phosphatase‑to‑albumin ratio in patients with hepatocellular carcinoma after hepatic resection.

Wang Y, Bi X, Zhao H, Li Z, Zhao J, Zhou J, Huang Z, Zhang Y, Chen X, Zhang C, Cai J, Ren Y. Wang Y, et al. Among authors: huang z. Oncol Lett. 2023 Mar 1;25(4):147. doi: 10.3892/ol.2023.13733. eCollection 2023 Apr. Oncol Lett. 2023. PMID: 36936019 Free PMC article.

3

An elevated preoperative cholesterol-to-lymphocyte ratio predicts unfavourable outcomes in colorectal cancer liver metastasis patients receiving simultaneous resections: a retrospective study.

Deng Y, Chen Q, Chen J, Zhang Y, Zhao J, Bi X, Li Z, Zhang Y, Huang Z, Cai J, Zhao H. Deng Y, et al. Among authors: huang z. BMC Surg. 2023 May 16;23(1):131. doi: 10.1186/s12893-023-01988-7. BMC Surg. 2023. PMID: 37194000 Free PMC article.

4

The MAPS-CRAFITY score: a novel efficacy predictive tool for unresectable hepatocellular carcinoma treated with targeted therapy plus immunotherapy.

Ouyang J, Yang Y, Zhou Y, Ye F, Wang Z, Li Q, Xu Y, Li L, Zhao X, Zhang W, Zhou A, Huang Z, Wang Y, Cai J, Zhao H, Zhou J. Ouyang J, et al. Among authors: huang z. Hepatol Int. 2023 Dec;17(6):1519-1531. doi: 10.1007/s12072-023-10580-3. Epub 2023 Sep 14. Hepatol Int. 2023. PMID: 37707759

5

Reclassification of therapeutic response of unresectable hepatocellular carcinoma to anti-angiogenic therapy and immunotherapy using alpha RECIST.

Xu Y, Yang Y, Ouyang J, Zhou Y, Li L, Ye F, Yang H, Huang Z, Zhou A, Zhang W, Zhou J, Zhao X, Zhao H. Xu Y, et al. Among authors: huang z. Eur Radiol. 2024 Apr;34(4):2244-2255. doi: 10.1007/s00330-023-10222-0. Epub 2023 Sep 23. Eur Radiol. 2024. PMID: 37740779

6

A CT-based radiomics approach to predict intra-tumoral tertiary lymphoid structures and recurrence of intrahepatic cholangiocarcinoma.

Xu Y, Li Z, Yang Y, Li L, Zhou Y, Ouyang J, Huang Z, Wang S, Xie L, Ye F, Zhou J, Ying J, Zhao H, Zhao X. Xu Y, et al. Among authors: huang z. Insights Imaging. 2023 Oct 15;14(1):173. doi: 10.1186/s13244-023-01527-1. Insights Imaging. 2023. PMID: 37840098 Free PMC article.

7

Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma.

Xu Y, Li Z, Zhou Y, Yang Y, Ouyang J, Li L, Huang Z, Ye F, Ying J, Zhao H, Zhou J, Zhao X. Xu Y, et al. Among authors: huang z. BMC Cancer. 2023 Oct 19;23(1):1009. doi: 10.1186/s12885-023-11476-z. BMC Cancer. 2023. PMID: 37858111 Free PMC article.

8

Association Between MRI Radiomics and Intratumoral Tertiary Lymphoid Structures in Intrahepatic Cholangiocarcinoma and Its Prognostic Significance.

Xu Y, Li Z, Yang Y, Zhang Y, Li L, Zhou Y, Ouyang J, Huang Z, Wang S, Xie L, Ye F, Zhou J, Ying J, Zhao H, Zhao X. Xu Y, et al. Among authors: huang z. J Magn Reson Imaging. 2023 Nov 9. doi: 10.1002/jmri.29128. Online ahead of print. J Magn Reson Imaging. 2023. PMID: 37942838

9

Chinese expert consensus on the overall management of liver function in conversion therapy for liver cancer (2022 edition).

Meng Q, Yang Z, Zhu Z, Li J, Bi X, Chen X, Hao C, Huang Z, Li F, Li X, Li G, Yang Y, Zhang Y, Zhao H, Zhao H, Zhu X, Zhu J, Cai J; Liver Tumor Branch of the China International Exchange and Promotive Association for Medical and Healthcare (CPAM); Gastrointestinal Cancer Multidisciplinary Cooperation Group of Cancer Hospital; Chinese Academy of Medical Sciences & Peking Union Medical College; Liver Cancer Professional Committee of Chinese Medical Doctor Association. Meng Q, et al. Among authors: huang z. Chin Med J (Engl). 2023 Dec 20;136(24):2909-2911. doi: 10.1097/CM9.0000000000002950. Epub 2023 Nov 27. Chin Med J (Engl). 2023. PMID: 38018217 Free PMC article. No abstract available.

10

The GRAPHS-CRAFITY score: a novel efficacy predictive tool for unresectable hepatocellular carcinoma treated with immunotherapy.

Yang Y, Li L, Xu Y, Ouyang J, Zhou Y, Ye F, Huang Z, Zhang W, Zhou A, Zhao X, Cai J, Wang Y, Zhou J, Zhao H. Yang Y, et al. Among authors: huang z. Radiol Med. 2024 Feb;129(2):188-201. doi: 10.1007/s11547-023-01753-z. Epub 2024 Jan 5. Radiol Med. 2024. PMID: 38180570

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28,350 results

Search Page